UY29158A1 - METHODS OF TREATMENT OF EPILEPTOGENESIS AND EPILEPSY - Google Patents

METHODS OF TREATMENT OF EPILEPTOGENESIS AND EPILEPSY

Info

Publication number
UY29158A1
UY29158A1 UY29158A UY29158A UY29158A1 UY 29158 A1 UY29158 A1 UY 29158A1 UY 29158 A UY29158 A UY 29158A UY 29158 A UY29158 A UY 29158A UY 29158 A1 UY29158 A1 UY 29158A1
Authority
UY
Uruguay
Prior art keywords
group
alkyl
epileptogenesis
epilepsy
methods
Prior art date
Application number
UY29158A
Other languages
Spanish (es)
Inventor
Roy E Twyman
Boyu Zhao
Gerald P Novak
Yong Moon Choi
Robert Gordon
Carlos R Plata-Salaman
Harold Steven White
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37600951&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29158(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of UY29158A1 publication Critical patent/UY29158A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Métodos para prevenir, tratar, revertir, inhibir o detener la epilepsia y la epileptogénesis en un sujeto, mediante una cantidad terapéuticamente efectiva de compuesto selecionado del grupo formado por Fórmulas (I) y (II), o una de sus sales o ésteres aceptables farmacéuticamente: donde fenilo está sustituido en X con uno a cinco átomos de halógeno seleccionados del grupo formado por flúor, cloro, bromo y yodo; y R1, R2, R3, R4, R5 y R6 seleccionados independientemente del grupo formado por hidrógeno y alquilo C1-C4; donde el alquilo C1-C4 está sustituido opcionalmente con fenilo; éste a su vez con sustituyentes seleccionados independientemente del grupo formado por halógeno, alquilo C1-C4, alcoxi C1-C4, amino, nitro y ciano).Methods to prevent, treat, reverse, inhibit or stop epilepsy and epileptogenesis in a subject, by a therapeutically effective amount of compound selected from the group consisting of Formulas (I) and (II), or one of its pharmaceutically acceptable salts or esters : where phenyl is substituted in X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and R1, R2, R3, R4, R5 and R6 independently selected from the group consisting of hydrogen and C1-C4 alkyl; wherein C1-C4 alkyl is optionally substituted with phenyl; this in turn with substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, amino, nitro and cyano).

UY29158A 2005-07-12 2005-10-07 METHODS OF TREATMENT OF EPILEPTOGENESIS AND EPILEPSY UY29158A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69862505P 2005-07-12 2005-07-12
US70724205P 2005-08-11 2005-08-11

Publications (1)

Publication Number Publication Date
UY29158A1 true UY29158A1 (en) 2005-11-30

Family

ID=37600951

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29158A UY29158A1 (en) 2005-07-12 2005-10-07 METHODS OF TREATMENT OF EPILEPTOGENESIS AND EPILEPSY

Country Status (4)

Country Link
AR (1) AR051314A1 (en)
PE (1) PE20061039A1 (en)
TW (1) TW200701978A (en)
UY (1) UY29158A1 (en)

Also Published As

Publication number Publication date
PE20061039A1 (en) 2006-11-08
AR051314A1 (en) 2007-01-03
TW200701978A (en) 2007-01-16

Similar Documents

Publication Publication Date Title
BRPI0515374A (en) Methods of treatment of epileptogenesis and epilepsy
ECSP088179A (en) CARBAMATE COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS
ECSP088172A (en) METHODS TO TREAT EPILEPTOGENESIS
AR054524A1 (en) METHODS AND DOSAGE FORMS TO REDUCE THE SIDE EFFECTS OF CARBAMATE COMPOUNDS
CO6180427A2 (en) TREATMENT OF THE GENERALIZED DISORDERS OF DEVELOPMENT
PE20091175A1 (en) BIS- (SULFONYLAMINE) DERIVATIVES IN THERAPY 205
PE20071132A1 (en) MACROCYCLIC COMPOUNDS AS INHIBITORS OF FACTOR VIIA
EA200800422A1 (en) METHODS OF TREATMENT OF DISEASES DETERMINED BY CHEMICALS
AR052885A1 (en) QT INTERVAL CONTROL METHODS
AR064241A1 (en) METHODS FOR THE TREATMENT OF DEPRESSION
ECSP077395A (en) CARBAMATE COMPOUND FOR USE IN THE TREATMENT OF NEURODEGENERATIVE PADCIMIENTS
CO6180505A2 (en) METHODS FOR THE TREATMENT OF COCLEAR AND VESTIBULAR DISORDERS
DK1408953T3 (en) Carbamate compounds for use in the prevention or treatment of bipolar disorder
CO6160292A2 (en) METHODS OF TREATMENT OF DISTURBING BEHAVIOR DISORDERS 877
AR032876A1 (en) CARBAMATE COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF PSYCHOTIC DISORDERS
UY29158A1 (en) METHODS OF TREATMENT OF EPILEPTOGENESIS AND EPILEPSY
CR9766A (en) METHODS FOR THE TREATMENT OF SUBSTANCE-RELATED DISORDERS
AR032907A1 (en) USE OF CARBAMATE COMPOUNDS FOR THE PREVENTION OR TREATMENT OF ANXIETY DISORDERS
AR033428A1 (en) CARBAMATE COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF BIPOLAR DISORDERS
AR035757A1 (en) USE OF CARBAMATES FOR THE MANUFACTURE OF MEDICINES TO PREVENT OR TREAT A BIPOLAR DISORDER
PE20060559A1 (en) CARBAMATE-DERIVED COMPOUNDS FOR THE TREATMENT OF SUBSTANCE-RELATED DISORDERS
AR034785A1 (en) CARBAMATE COMPOUNDS TO BE USED IN THE PREVENTION OR TREATMENT OF NEUROPATHIC PAIN AND PAIN ASSOCIATED WITH MIGRANEOUS HEAD AND ACCUMINATED HEAD
CY1110672T1 (en) USE OF 2- FENYL-1,2-ETHANODIOL- (DI) CARBAMIC FOR SELECTION THERAPY
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders
TH86239B (en) How to treat epilepsy